- Report
- January 2024
- 92 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- August 2023
- 91 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- January 2024
- 94 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- March 2021
- 98 Pages
Global
€21210EUR$22,000USD£18,140GBP
- Report
- February 2019
- 14 Pages
United States
From €577EUR$599USD£494GBP
- Book
- January 2020
- 207 Pages
- Book
- December 2018
- 277 Pages
From €124EUR$129USD£106GBP
- Book
- October 2019
- 382 Pages
- Report
- September 2023
- 200 Pages
Global
From €2891EUR$2,999USD£2,473GBP
- Report
- February 2021
- 109 Pages
United States
From €3517EUR$3,648USD£3,008GBP
- Book
- May 2023
- 416 Pages
- Book
- May 2023
- 272 Pages
- Book
- April 2023
- 688 Pages
- Book
- December 2022
- 400 Pages
- Book
- September 2022
- 480 Pages
- Book
- July 2022
- 880 Pages
- Book
- August 2019
- 264 Pages
Heart failure is a condition in which the heart is unable to pump enough blood to meet the body's needs. It is a major cause of death and disability in cardiology, and is a growing public health concern. Heart failure can be caused by a variety of conditions, including coronary artery disease, high blood pressure, and diabetes. Treatment typically involves lifestyle changes, medications, and in some cases, surgery.
The heart failure market is a rapidly growing segment of the cardiology industry. It is driven by an aging population, increasing prevalence of chronic diseases, and advances in medical technology. Companies in this market are focused on developing treatments and technologies to improve the diagnosis and management of heart failure. These include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples of companies in this market include Novartis, Medtronic, and Abbott. Show Less Read more